ICD-10 code D06.1: Carcinoma in situ of exocervix

Key Takeaways

ICD-10 code D06.1 is a billable diagnosis code for carcinoma in situ of the exocervix, valid for FY 2026 and restricted to female patients only

D06.1 is distinct from D06.0 (endocervix) and D06.9 (unspecified cervix), chosen based on the anatomical site named in the pathology report

A Type 1 Excludes note prohibits coding D06.1 simultaneously with N87.1 (CIN II), a common documentation error in gynecologic practices

Pabau’s claims management and clinical documentation tools support accurate gynecologic coding workflows for OB/GYN practices

ICD-10 code D06.1 is the billable, female-only diagnosis code for carcinoma in situ of the exocervix. It covers squamous cell changes confined to the outer, vaginally visible portion of the cervix, with no invasion into surrounding tissue.

D06.0 applies to the same finding in the endocervix, and D06.9 applies when the pathology report doesn’t specify a site. This guide covers the code definition, documentation requirements, and the coding rules that govern the D06 category for gynecologic billing in 2026.

ICD-10 code D06.1: Definition and clinical description

ICD-10 code D06.1 designates carcinoma in situ of the exocervix, classified under the D00-D09 in situ neoplasms chapter of the ICD-10-CM system maintained by CDC/NCHS. The code is billable, gender-specific (female patients only), and remains valid and unchanged for FY 2026.

Carcinoma in situ (CIS) describes a localized proliferation of malignant-appearing epithelial cells that have not yet invaded surrounding tissue. The exocervix, also called the ectocervix, is the portion of the cervix that projects into the vaginal canal and is visible on speculum examination.

It is lined with squamous epithelium, making it the primary site for squamous cell carcinoma in situ arising at or near the transformation zone. The WHO ICD-10 classification places D06.1 within the broader D06 category for carcinoma in situ of the cervix uteri, alongside D06.0 (endocervix), D06.7 (other parts of cervix), and D06.9 (unspecified).

For OB/GYN practices billing cervical dysplasia and surveillance visits, selecting the most specific subcategory code is essential for clean claim submission.

D06.1 code details and billable status

The table below summarizes the key administrative and clinical attributes of ICD-10 code D06.1 for quick reference during documentation and claim preparation.

Because D06.1 is restricted to female patients, any claim submitted against a male patient ID will trigger an immediate edit rejection. Verify patient demographics in your clinical documentation system before submission.

D06 category codes: Exocervix, endocervix, and related cervical in situ codes

The D06 category contains four billable subcategory codes. Selecting the wrong one is one of the most common errors in gynecologic coding, particularly when pathology reports use imprecise anatomical language. The CMS ICD-10-CM guidelines require coding to the highest level of specificity supported by the documentation.

The most common documentation scenario is a colposcopy-directed biopsy report that returns “squamous cell carcinoma in situ, exocervix.” That language maps directly to D06.1. If the report reads “carcinoma in situ, cervix” without further specification, the correct code is D06.9.

Never assume exocervix involvement without explicit documentation. For practices using digital intake and consent forms linked to clinical notes, structured pathology reporting templates can pre-populate the anatomical site field and reduce ambiguity at coding time.

Coding rules and Excludes notes for ICD-10 code D06.1

The D06 category carries a Type 1 Excludes note for cervical intraepithelial neoplasia II (CIN II), coded as N87.1. This is the most clinically consequential coding rule in the category, and one of the most frequently violated.

Understanding what CIN grades map to within ICD-10-CM prevents costly claim errors. Structured clinical documentation software can flag Excludes-note conflicts like this one before submission.

Type 1 Excludes: D06 vs N87.1

A Type 1 Excludes note means the two conditions cannot be coded simultaneously on the same claim. D06.1 and N87.1 (moderate cervical dysplasia, CIN II) must never appear together. CIN II and carcinoma in situ represent different histological grades with different ICD-10-CM assignments, so the classification separates them by design.

• CIN I (mild dysplasia): N87.0 – not excluded from D06, but only code one
• CIN II (moderate dysplasia): N87.1 – Type 1 Excludes with all D06 codes
• CIN III / carcinoma in situ: Maps to D06.x (not N87.x)
• Unspecified cervical dysplasia: N87.9 – does not carry an Excludes1 note with D06

In practice, a pathologist may report “CIN III with features of carcinoma in situ, exocervix.” The correct ICD-10-CM code is D06.1, not a combination of N87.x and D06.1.

Document the histological findings verbatim in the clinical note, and select the single most appropriate code. AI clinical documentation tools can capture this level of detail directly from dictation.

Female-only designation

ICD-10 code D06.1 is designated for female patients only. Claims submitted against male patient records will fail front-end edits automatically. This is a non-negotiable administrative constraint built into the code’s definition. Practices using gender-aware claims management workflows can configure validation rules to catch this error before submission.

CIN grading and ICD-10 code D06.1: Understanding the relationship

Cervical intraepithelial neoplasia (CIN) and carcinoma in situ are related but not interchangeable in ICD-10-CM coding. CIN is a graded histopathological classification, while carcinoma in situ is a specific diagnosis. Cervical intraepithelial neoplasia grade 3 (CIN 3) is the grade where a cervical lesion crosses from the N87 dysplasia codes into the D06 carcinoma in situ family.

High-grade squamous intraepithelial lesion (HSIL) on cytology does not directly map to D06.1. Histological confirmation from a biopsy is required. The AAPC Codify ICD-10-CM lookup provides index entries for carcinoma in situ, cervix uteri that route to the D06 category with site-specific subcategories.

Always use the tabular list for final code assignment. For practices tracking HPV-related gynecologic diagnoses across patient records, structured clinical documentation workflows allow coders and clinicians to build consistent cytology and histology fields into encounter notes.

Streamline gynecologic coding documentation

Pabau helps OB/GYN practices manage clinical notes, pathology results, and claims submissions in one system, reducing ICD-10 coding errors at the source.

Book a demo

Related ICD-10 codes and neoplasm table crosswalk

The CDC’s ICD-10-CM neoplasm table maps several anatomical cervical terms to D06.1 as the in situ designation. The table below covers the most clinically relevant adjacent codes for gynecologic and oncology coding workflows.

Not every gynecologic encounter involves a suspicious finding. A routine, normal visit codes to ICD-10 code Z01.419, distinct from every code in the table above.

When a cervical biopsy confirms invasion beyond the basement membrane, D06.1 no longer applies. The diagnosis transitions to C53.1, malignant neoplasm of exocervix.

This transition point requires specific documentation language in the pathology report, and coders should not infer invasiveness from clinical context alone. The AAPC Codify index referenced above also routes equivalent, non-standard terminology for carcinoma in situ back to the correct D06 subcategory.

More ICD-10 and CPT code guides

Pabau publishes new ICD-10 and CPT coding guides daily. Recent additions include:

• ICD-10 code M35.6
• ICD-10 code M17.9
• ICD-10 code H51.8
• ICD-10 code I45.4
• CPT code 99100
• CPT code 36415

Documentation requirements for accurate D06.1 coding

Every D06.1 claim requires supporting clinical documentation that clearly establishes the diagnosis, the anatomical site, and the basis for the finding. Payers can and do request records for gynecologic oncology claims, particularly those supporting procedural codes for colposcopy, LEEP, or cone biopsy. For practices building consistent gynecologic documentation templates, compliance documentation tools can standardize the required elements across providers.

Required documentation elements

• Histological confirmation: A pathology report explicitly identifying “carcinoma in situ” of the “exocervix” or “ectocervix” is the primary source document for D06.1
• Anatomical site specificity: Documentation must distinguish between exocervix (D06.1), endocervix (D06.0), or other cervical site (D06.7); “cervix” alone supports D06.9 only
• Absence of invasion: Notes must confirm no stromal invasion for in situ classification; microinvasion or frank invasion shifts the code to C53.1
• HPV association: While HPV status does not change the D06.1 code, HPV typing results should be documented separately for medical record completeness
• Procedure correlation: If a LEEP, cone biopsy, or colposcopy was performed on the same date, the operative and pathology reports must align with the diagnosis code

When PHI needs to move between the referring provider and the pathology lab, a signed HIPAA authorization form should sit in the same encounter record as the pathology report.

Coding from cytology results alone, such as a Pap smear showing HSIL, is not appropriate for D06.1. The code requires histological confirmation from a tissue specimen. Per CMS ICD-10-CM coding guidelines, code the confirmed diagnosis, not the sign, symptom, or cytological finding that prompted the workup.

Standardized encounter notes using HIPAA compliance software help practices capture pathology correlation fields consistently across all providers.

Billing and workflow context for ICD-10 code D06.1

D06.1 is most commonly paired with CPT procedure codes for diagnostic and therapeutic gynecologic procedures. Understanding the typical code combinations reduces claim denials and keeps medical necessity documentation aligned.

Practices supporting gynecologic care alongside broader reproductive health services can review fertility practice software for integrated coding support. Understanding medical billing fundamentals also helps front-desk staff catch code pairing errors before submission.

Commonly paired CPT codes

Medical necessity documentation for LEEP or cone biopsy paired with D06.1 should reference the pathology report date, the specific site excised, and any prior colposcopic findings. Payers conducting post-payment audits look for temporal alignment between the procedure date and pathology date.

Automated claims management workflows can build D06.1 into gynecologic coding templates so the pathology reference is captured consistently. Practices can also track revenue cycle management metrics to spot D06.1 denials early, and compare options with a medical billing software guide. HIPAA mandates use of ICD-10-CM codes for all covered healthcare transactions, detailed at Pabau’s HIPAA compliance resource.

Code D06.1 with confidence

ICD-10 code D06.1 is a straightforward code with a narrow but consequential set of rules. Using D06.9 when the pathology report supports D06.1 loses the specificity the payer expects. Coding D06.1 alongside N87.1 violates a Type 1 Excludes note.

Assigning D06.1 after invasion is confirmed produces the wrong neoplasm category entirely. Each of these errors is preventable with structured clinical documentation that captures the anatomical site, histological grade, and invasion status at the time of the encounter.

Get the documentation right at the encounter and the correct code follows, so claims go out clean and your team isn’t rebuilding pathology details for an audit weeks later.

Pabau keeps structured encounter notes, pathology results, and claims in one place, so the anatomical site, histological grade, and invasion status that D06.1 hinges on are captured up front. See how it helps your OB/GYN practice code D06.1 right the first time. Book a demo.

Continue your research

Need software built for OB/GYN documentation? OB/GYN EMR software covers the clinical workflows specific to gynecologic practices, from structured visit notes to billing integration.

Want to standardize your gynecologic intake and consent process? Capture forms software lets practices build structured form templates that pre-populate clinical documentation fields for consistent data capture.

Looking for a specialty-specific EHR comparison? gynecology EHR software compares the platforms built for gynecologic documentation, coding, and billing workflows.

Frequently asked questions